Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Dihydroergotamine Mesylate Injection, USP
Medication labelWhy this: Advisory · dailymed-prescription
Dihydroergotamine Mesylate Injection is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.
- generic_name
- dihydroergotamine mesylate
- product_names
- Dihydroergotamine Mesylate
- ndc
- 68083-466, 68083-466-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en